지질 조절제 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 유형별, 지역별, 경쟁별(2020-2030년)
Lipid Regulators Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Region and Competition, 2020-2030F
상품코드:1714391
리서치사:TechSci Research
발행일:2025년 04월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
지질 조절제 세계 시장 규모는 2024년 72억 1,000만 달러로 2030년에는 98억 4,000만 달러에 달할 것으로 예상되며, 예측 기간 동안 연평균 5.32%의 CAGR로 성장할 것으로 예상됩니다.
이 시장은 심혈관질환과 당뇨병의 전 세계 발병률 증가, 인구 고령화, 콜레스테롤 관리에 대한 인식 증가 등을 배경으로 꾸준한 성장세를 보이고 있습니다. 기술 혁신, 특히 신경 및 치료법의 발전, 정부 및 민간 부문의 투자 확대는 시장 확대에 유리한 여건을 조성하고 있습니다. 노년층은 만성질환에 걸리기 쉬우며, 이상지질혈증 관리 및 합병증 예방에 필수적인 지질 조절제의 수요는 증가할 것으로 예상되며, 예방적 심혈관 치료의 중요성이 커지고 있습니다.
The Global Lipid Regulators Market was valued at USD 7.21 billion in 2024 and is projected to reach USD 9.84 billion by 2030, growing at a CAGR of 5.32% during the forecast period. The market is experiencing steady growth driven by a rising global incidence of cardiovascular diseases and diabetes, an aging population, and increasing awareness of cholesterol management. Technological innovations, particularly in neural and therapeutic advancements, as well as increased government and private sector investments, are creating favorable conditions for market expansion. With the elderly being more vulnerable to chronic illnesses, the demand for lipid regulators-essential in managing dyslipidemia and preventing complications-is anticipated to increase, reinforcing their importance in preventive cardiovascular care.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 7.21 Billion
Market Size 2030
USD 9.84 Billion
CAGR 2025-2030
5.32%
Fastest Growing Segment
Statins
Largest Market
North America
Key Market Drivers
Rising Prevalence of Cardiovascular Diseases
The global surge in cardiovascular diseases (CVDs) serves as a key catalyst for the lipid regulators market. CVDs, including coronary artery disease, stroke, and hypertension, are a leading cause of death globally. According to the World Health Organization, CVDs account for nearly 32% of all deaths worldwide. Dyslipidemia, characterized by abnormal cholesterol or triglyceride levels, is a primary risk factor in the development of CVDs. Lipid regulators, particularly statins and other lipid-lowering agents, are vital in controlling cholesterol levels, reducing disease progression, and improving patient outcomes. With a growing global focus on preventive healthcare, the demand for lipid-regulating therapies continues to rise, offering growth opportunities for pharmaceutical companies and healthcare providers.
Key Market Challenges
High Development Costs
High development costs remain a major challenge in the lipid regulators market. The process of discovering, developing, and commercializing new lipid-lowering drugs involves extensive R&D, clinical trials, and regulatory approvals, all of which require substantial financial investment. Preclinical and clinical research phases are time-consuming and expensive, involving the recruitment of skilled professionals and maintenance of specialized facilities. Additionally, ensuring safety and efficacy through compliance with stringent regulatory frameworks adds further financial burden. These cost-related barriers particularly affect smaller pharmaceutical firms, potentially limiting innovation and delaying market entry of newer lipid-regulating products.
Key Market Trends
Rise of Biopharmaceuticals
Biopharmaceuticals are reshaping the lipid regulators market by enabling more targeted, effective treatment options. Unlike traditional chemical-based drugs, biopharmaceuticals-such as monoclonal antibodies and recombinant proteins-interact with specific biological pathways to regulate lipid metabolism. These advanced therapies offer improved safety profiles and enhanced therapeutic outcomes, particularly for patients who are unresponsive to conventional statins. The advancement of technologies like gene editing and synthetic biology is accelerating the development of biologics. While the infrastructure and expertise required for biopharmaceutical development present initial investment challenges, the long-term benefits-such as premium pricing and extended patent exclusivity-make them a lucrative segment within the lipid regulators market.
Key Market Players
AbbVie Inc
Amgen Inc.
Andrx Corp
AstraZeneca PLC
Bristol-Myers Squibb Co
Merck KGaA
Novartis AG
Pfizer Inc.
Teva Pharmaceutical Industries Ltd
Dr. Reddy's Laboratories Ltd.
Report Scope:
In this report, the Lipid Regulators Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Lipid Regulators Market, By Type:
Statins (Branded statins, Statin combinations, and Generic statins)
Non-statins (Fibric-acid derivatives, Bile-acid Sequestrants, Nicotinic Acid Derivatives, and Other New Products)
Lipid Regulators Market, By Region:
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
Italy
France
Spain
Asia Pacific
China
India
Japan
South Korea
Australia
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Lipid Regulators Market.
Available Customizations:
Lipid Regulators Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Lipid Regulators Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type {Statins (Branded statins, Statin combinations, and Generic statins), and Non-statins (Fibric-acid derivatives, Bile-acid Sequestrants, Nicotinic Acid Derivatives, and Other New Products)}
5.2.2. By Region
5.2.3. By Company (2024)
5.3. Market Map
6. North America Lipid Regulators Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Country
6.3. North America: Country Analysis
6.3.1. United States Lipid Regulators Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.2. Canada Lipid Regulators Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.3. Mexico Lipid Regulators Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
7. Europe Lipid Regulators Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Lipid Regulators Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.2. United Kingdom Lipid Regulators Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.3. Italy Lipid Regulators Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecasty
7.3.3.2.1. By Type
7.3.4. France Lipid Regulators Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.5. Spain Lipid Regulators Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
8. Asia-Pacific Lipid Regulators Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Lipid Regulators Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.2. India Lipid Regulators Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.3. Japan Lipid Regulators Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.4. South Korea Lipid Regulators Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.5. Australia Lipid Regulators Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
9. South America Lipid Regulators Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Lipid Regulators Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.2. Argentina Lipid Regulators Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.3. Colombia Lipid Regulators Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
10. Middle East and Africa Lipid Regulators Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Lipid Regulators Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.2. Saudi Arabia Lipid Regulators Market Outlook
